Literature DB >> 32011641

Refocusing Medication Prior Authorization on Its Intended Purpose.

Jack S Resneck1,2.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 32011641     DOI： 10.1001/jama.2019.21428

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  12 in total

Review 1.  Organizational Evidence-Based and Promising Practices for Improving Clinician Well-Being.

Authors:  Christine A Sinsky; Lee Daugherty Biddison; Aditi Mallick; Anna Legreid Dopp; Jessica Perlo; Lorna Lynn; Cynthia D Smith
Journal:  NAM Perspect       Date:  2020-11-02

2.  Implications for cost and access of site-of-service referrals for ancillary medical services in a US Medicaid population: analysis of claims data from Maryland, USA.

Authors:  Simrita Singh; Kelsey J Rydland; Chester Chambers; Vishal Mundlye; Edward Kumian; Kayode Ayodele Williams; Maqbool Dada
Journal:  BMJ Open       Date:  2022-06-17       Impact factor: 3.006

Review 3.  Economic Issues in Heart Failure in the United States.

Authors:  Paul A Heidenreich; Gregg C Fonarow; Yekaterina Opsha; Alexander T Sandhu; Nancy K Sweitzer; Haider J Warraich
Journal:  J Card Fail       Date:  2022-01-24       Impact factor: 6.592

4.  Measuring the Scope of Prior Authorization Policies: Applying Private Insurer Rules to Medicare Part B.

Authors:  Aaron L Schwartz; Troyen A Brennan; Dorothea J Verbrugge; Joseph P Newhouse
Journal:  JAMA Health Forum       Date:  2021-05-28

5.  Incidence and Predictors of Primary Nonadherence to Sodium Glucose Co-transporter 2 Inhibitors and Glucagon-Like Peptide 1 Agonists in a Large Integrated Healthcare System.

Authors:  Jing Luo; Robert Feldman; Scott Rothenberger; Mary Korytkowski; Michael A Fischer; Walid F Gellad
Journal:  J Gen Intern Med       Date:  2022-01-19       Impact factor: 6.473

6.  Managing prior approval for site-of-service referrals: an algorithmic approach.

Authors:  Maqbool Dada; Vishal Mundly; Chester G Chambers; Mohammad Ali Alamdar Yazdi; Changhun Ha; Sonia E Toporcer; Yi Zhou; Yunong Gan; Zhihua Xing; Mark Mooney; Ernest Smith; Edward Kumian; Kayode A Williams
Journal:  BMC Health Serv Res       Date:  2022-02-14       Impact factor: 2.655

7.  2021 National Survey on Prior Authorization Burden and Its Impact on Gastroenterology Practice.

Authors:  Eric D Shah; Stephen T Amann; James Hobley; Sameer Islam; Raja Taunk; Louis Wilson
Journal:  Am J Gastroenterol       Date:  2022-03-17       Impact factor: 10.864

8.  Impact of implementing electronic prior authorization on medication filling in an electronic health record system in a large healthcare system.

Authors:  Julie C Lauffenburger; Cheryl D Stults; Satish Mudiganti; Xiaowei Yan; Lisa M Dean-Gilley; Mengdong He; Angela Tong; Michael A Fischer
Journal:  J Am Med Inform Assoc       Date:  2021-09-18       Impact factor: 7.942

9.  Will prior health insurance authorization for medications continue to hinder hepatitis C treatment delivery in the United States? Perspectives from hepatitis C treatment providers in a large urban healthcare system.

Authors:  Marjan Javanbakht; Roxanne Archer; Jeffrey Klausner
Journal:  PLoS One       Date:  2020-11-04       Impact factor: 3.240

10.  Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus.

Authors:  Arash A Nargesi; Gini P Jeyashanmugaraja; Nihar Desai; Kasia Lipska; Harlan Krumholz; Rohan Khera
Journal:  J Am Heart Assoc       Date:  2021-05-15       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.